NephroGenex (NRX) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts NRX Hot Sheet
Join SI Premium – FREE
NephroGenex (NASDAQ: NRX) reported Q1 EPS of ($0.58), $0.04 better than the analyst estimate of ($0.62).
For earnings history and earnings-related data on NephroGenex (NRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Piper Sandler Upgrades Halliburton (HAL) to Overweight
- Jefferies Upgrades Friedrich Vorwerk Group SE (VH2:GR) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
